Guanidinoacetic acid with creatine compared with creatine alone for tissue creatine content, hyperhomocysteinemia, and exercise performance: A randomized, double-blind superiority trial

Nutrition. 2019 Jan:57:162-166. doi: 10.1016/j.nut.2018.04.009. Epub 2018 May 17.

Abstract

Purpose: Co-administration of creatine and guanidinoacetic acid (GAA) has been recently put forward as an advanced dietary strategy to optimize tissue bioenergetics. We hypothesized that creatine-GAA mixture would result in a more powerful rise in brain and skeletal muscle creatine, as compared to creatine supplementation alone.

Methods: A randomized, double-blinded, crossover superiority trial has been performed at the University of Novi Sad from December 2016 to November 2017. A total of 14 healthy young men were randomized to receive GAA-creatine mixture (1 grams of GAA and 3 grams of creatine per day) or equimolar creatine (4 grams per day) by oral administration for 4 weeks.

Results: Creatine-GAA mixture was superior to creatine alone to increase mean creatine levels in skeletal muscle (16.9 ± 20.2 vs. 2.0 ± 6.0%; P = 0.02) and grey matter (5.8 ± 5.3% vs. 1.5 ± 3.2%; P = 0.02), also for bench press performance (6.0% vs. 5.1%; P < 0.01). Compared with creatine administration alone, combined GAA and creatine resulted in less weight gain (1.6 ± 0.2 kg vs. 0.7 ± 0.2 kg; P < 0.01). No inter-group differences were observed in terms of cardiorespiratory endurance, serum biomarkers, or adverse events.

Conclusions: Creatine-GAA mixture appeared to be superior to creatine alone for up-swinging tissue creatine content and upper body strength, and tended toward a lower risk of weight gain in healthy active men. The formulation might be considered as a novel energy-boosting alternative to creatine alone in weight-sensitive setups.

Trial registration: ClinicalTrials.govNCT03350282.

Keywords: Brain; Creatine; Eexercise performance; Guanidinoacetic acid; MR spectroscopy; Skeletal muscle.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Brain / drug effects*
  • Brain / metabolism
  • Creatine / metabolism
  • Creatine / pharmacology
  • Creatine / therapeutic use*
  • Cross-Over Studies
  • Dietary Supplements*
  • Double-Blind Method
  • Drug Combinations
  • Energy Metabolism / drug effects
  • Exercise / physiology*
  • Glycine / analogs & derivatives*
  • Glycine / pharmacology
  • Glycine / therapeutic use
  • Humans
  • Hyperhomocysteinemia* / epidemiology
  • Hyperhomocysteinemia* / etiology
  • Male
  • Muscle Strength / drug effects
  • Muscle, Skeletal / drug effects*
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / physiology
  • Physical Endurance
  • Reference Values
  • Resistance Training
  • Weight Gain / drug effects
  • Young Adult

Substances

  • Biomarkers
  • Drug Combinations
  • glycocyamine
  • Creatine
  • Glycine

Associated data

  • ClinicalTrials.gov/NCT03350282